Postdoctoral Fellow - Hematologic Malignancies jobs in United States
cer-icon
Apply on Employer Site
company-logo

City of Hope · 6 hours ago

Postdoctoral Fellow - Hematologic Malignancies

City of Hope is at the forefront of groundbreaking research in the fight against cancer and other life-threatening illnesses. They are seeking a Postdoctoral Fellow to conduct basic and translational research on hematologic malignancies, focusing on the genetic and molecular mechanisms driving disease progression.

AssociationEducationHealth Care
check
Comp. & Benefits

Responsibilities

Lead independent and collaborative projects investigating the molecular and cellular basis of hematologic malignancies
Work with mouse models, human tumor samples, and high-throughput technologies (e.g., next-generation sequencing, flow cytometry, and immunohistochemistry)
Analyze genomic, transcriptomic, and phenotypic data to identify mechanisms of cancer progression and therapeutic resistance
Collaborate with a multidisciplinary team of scientists, pathologists, and clinicians
Contribute to the preparation of high-impact publications, grant proposals, and scientific presentations
Receive mentorship in experimental design, translational research, and career development

Qualification

PhD in molecular biologyFlow cytometryNext-generation sequencingImmunohistochemistryRNA/DNA analysisCancer biologyExperimental designScientific presentationsCollaboration

Required

A PhD, MD or MD/PhD in molecular biology, cancer genetics, cancer biology, pathology, immunology, or a related biomedical field
Familiarity with flow cytometry, RNA/DNA analysis, immunohistochemistry, or genomic technologies
Demonstrated productivity through peer-reviewed publications

Preferred

Strong research background in genetic engineered mouse modeling, molecular and cellular biology; experience with hematologic malignancies or cancer genomics is preferred

Benefits

Comprehensive Benefits

Company

City of Hope

company-logo
City of Hope is a cancer research and treatment non-profit organization specializing in diabetes and other life-threatening illnesses.

Funding

Current Stage
Late Stage
Total Funding
$10.3M
Key Investors
California Institute for Regenerative Medicine
2024-05-20Grant· $5.4M
2022-02-22Grant· $4.9M

Leadership Team

leader-logo
Samuel Lau
Vice President Marketing & Digital Communications
linkedin
leader-logo
Alan H. Bryce
Chief Clinical Officer
linkedin
Company data provided by crunchbase